Explore

Trendline Trendline
VentriPoint Diagnostics Expands Global Footprint with AI-Powered Cardiac Imaging

VentriPoint Diagnostics Expands Global Footprint with AI-Powered Cardiac Imaging

VentriPoint Diagnostics Expands Global Footprint with AI-Powered Cardiac Imaging
Rapid Read Rapid Read
Boehringer and Brainomix Launch New Trial for AI-Driven Lung Fibrosis Diagnosis

Boehringer and Brainomix Launch New Trial for AI-Driven Lung Fibrosis Diagnosis

Boehringer Ingelheim, in collaboration with digital health company Brainomix, is expanding its efforts to improve the diagnosis of interstitial lung diseases (ILDs) through a new large-scale clinical trial. The trial will focus on the use of Brainomix's e-Lung software, an AI-enabled tool designed to assist in diagnosing conditions such as progressive pulmonary fibrosis (PPF). This initiative follows the retrospective REVISE-PPF study, which demonstrated that e-Lung could potentially reduce diagnosis times by over two years. The upcoming PROGRESS-PPF study will be conducted at multiple pulmonary care sites across the U.S., aiming to validate the software's effectiveness in real-world clinical settings. The goal is to determine if routine use of e-Lung can facilitate earlier diagnosis and treatment, thereby improving patient outcomes.
Trendline Trendline
Tech Companies Invest in AI-Powered Wearables to Predict Health Risks

Tech Companies Invest in AI-Powered Wearables to Predict Health Risks

Tech Companies Invest in AI-Powered Wearables to Predict Health Risks
Rapid Read Rapid Read
Renalytix and Carna Health Partner to Transform Chronic Kidney Disease Management in the U.S.

Renalytix and Carna Health Partner to Transform Chronic Kidney Disease Management in the U.S.

Renalytix PLC, a precision medicine diagnostics company, and Carna Health, an AI-enabled digital health company, have announced a partnership aimed at revolutionizing the management of chronic kidney disease (CKD) in the United States. This collaboration integrates Renalytix's FDA-approved kidneyintelX.dkd test with Carna Health's digital health platform to provide a comprehensive CKD management system. The initiative seeks to identify at-risk patients earlier, manage risks proactively, and improve patient outcomes under value-based care models. The partnership addresses the economic burden of CKD, which costs Medicare over $130 billion annually, by offering a preemptive, actionable roadmap for clinicians and patients.
Trendline Trendline
Omada Health Reports 42% Revenue Increase in Q1, Partners with Eli Lilly for Employer Weight Loss Program

Omada Health Reports 42% Revenue Increase in Q1, Partners with Eli Lilly for Employer Weight Loss Program

Omada Health Reports 42% Revenue Increase in Q1, Partners with Eli Lilly for Employer Weight Loss Program
Rapid Read Rapid Read
The Galien Foundation Announces 2026 Prix Galien UK Award Candidates for Medical Innovation

The Galien Foundation Announces 2026 Prix Galien UK Award Candidates for Medical Innovation

The Galien Foundation has announced the candidates for the 2026 Prix Galien UK Awards, which recognize excellence in life sciences innovation. The awards cover categories such as Best Biotechnology Product, Best Digital Health Solution, Best Medical Technology, Best Pharmaceutical Product, Best Public Sector Innovation, and Best Health Equity Innovation. The winners will be announced at a ceremony on June 11, 2026, at the Natural History Museum in London. The Prix Galien is considered a prestigious accolade in the field of biopharmaceutical research, akin to the Nobel Prize. The awards aim to honor the collaborative and multidisciplinary efforts that drive advancements in medical science and improve patient outcomes globally.
Trendline Trendline
bioAffinity Technologies Achieves Record Sales for CyPath® Lung Diagnostic Test in April 2026

bioAffinity Technologies Achieves Record Sales for CyPath® Lung Diagnostic Test in April 2026

bioAffinity Technologies Achieves Record Sales for CyPath® Lung Diagnostic Test in April 2026
Trendline Trendline
Peloton Introduces AI-Powered Coaching System to Enhance User Experience

Peloton Introduces AI-Powered Coaching System to Enhance User Experience

Peloton Introduces AI-Powered Coaching System to Enhance User Experience
Trendline Trendline
CVRx Reports Q1 Revenue Growth Driven by U.S. Heart Failure Business

CVRx Reports Q1 Revenue Growth Driven by U.S. Heart Failure Business

CVRx Reports Q1 Revenue Growth Driven by U.S. Heart Failure Business
Rapid Read Rapid Read
AMA Introduces Framework to Combat AI Deepfake Physician Impersonation

AMA Introduces Framework to Combat AI Deepfake Physician Impersonation

The American Medical Association (AMA) has unveiled a comprehensive policy framework aimed at protecting physicians from unauthorized AI-generated deepfakes. This initiative, developed by the AMA's Center for Digital Health and AI, seeks to modernize identity protections for physicians and address legal gaps. The framework is built on seven policy principles, including the protection of physician identity as a right, prohibition of deceptive impersonation, and mandatory transparency. AMA CEO John Whyte, M.D., emphasized the public health and safety risks posed by deepfakes, which can undermine patient trust and lead to harmful, unproven care. The AMA is calling for strong action from federal and state lawmakers to safeguard professional integrity in the digital age.
Trendline Trendline
IoT Integration in Agriculture Surges, Faces Challenges in Healthcare

IoT Integration in Agriculture Surges, Faces Challenges in Healthcare

IoT Integration in Agriculture Surges, Faces Challenges in Healthcare
Rapid Read Rapid Read
Bayesian Health Achieves FDA Clearance for AI Sepsis Monitoring System

Bayesian Health Achieves FDA Clearance for AI Sepsis Monitoring System

Bayesian Health has received FDA 510(k) clearance for its continuous AI sepsis monitoring system, marking the first such approval for a continuous AI sepsis monitor. This system is part of Bayesian's real-time clinical intelligence platform, designed to enhance early detection of sepsis by continuously monitoring patient data and alerting clinicians to potential issues before they become critical. The platform integrates with existing electronic health records (EHRs) to provide a proactive layer of clinical intelligence, aiming to improve patient outcomes by enabling earlier intervention.